Pubblicazioni

Autoimmune pancreatitis not otherwise specified (NOS): Clinical features and outcomes of the forgotten type  (2019)

Autori:
de Pretis, Nicolò; Vieceli, Filippo; Brandolese, Alessandro; Brozzi, Lorenzo; Amodio, Antonio; Frulloni, Luca
Titolo:
Autoimmune pancreatitis not otherwise specified (NOS): Clinical features and outcomes of the forgotten type
Anno:
2019
Tipologia prodotto:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Lingua:
Inglese
Formato:
A Stampa
Referee:
Nome rivista:
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL
ISSN Rivista:
1499-3872
N° Volume:
18
Numero o Fascicolo:
6
Intervallo pagine:
576-579
Parole chiave:
Autoimmune pancreatitis; Follow-up; Not otherwise specified; Outcome; Therapy
Breve descrizione dei contenuti:
Background: Autoimmune pancreatitis (AIP) is a well-recognized fibroinflammatory disease of the pancreas. Despite the significant number of studies published on AIP type 1 and 2, no studies have been focused on AIP type not otherwise specified (NOS) and therefore very little is known about clinical features and long-term outcomes of these patients. The aim of this study was to investigate clinical and radiological features of AIP type NOS-patients.Methods: Patients classified as AIP type NOS at clinical onset included in our database prospectively maintained since 1995 were evaluated. Epidemiological, clinical data were collected and analyzed.Results: Forty-six patients were included in the study. The clinical onset was mainly characterized by weight loss, jaundice and acute pancreatitis. Eight patients (17.4%) were reclassified as AIP type 2 during follow-up because of the development of ulcerative colitis. Seven patients (15.2%) experienced relapse after steroid treatment but only one (2.2%) needed immunosuppressive drugs because of recurrent relapses.Conclusions: AIP type NOS shares clinical features similar to AIP type 2 and a relevant proportion of patients was reclassified as AIP type 2 during follow-up because of the development of ulcerative colitis. The risk of relapse is low but not irrelevant. (C) 2019 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.
Id prodotto:
113929
Handle IRIS:
11562/1015643
ultima modifica:
28 novembre 2022
Citazione bibliografica:
de Pretis, Nicolò; Vieceli, Filippo; Brandolese, Alessandro; Brozzi, Lorenzo; Amodio, Antonio; Frulloni, Luca, Autoimmune pancreatitis not otherwise specified (NOS): Clinical features and outcomes of the forgotten type «HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL» , vol. 18 , n. 62019pp. 576-579

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo IRIS

<<indietro

Attività

Strutture

Condividi